16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Menu
Ligand Predictions Analysis
Results Home Table Browser
Target: 
Text
Models / Ligands Ligand scores
    #     Model     Group
    Name		      Target Ligand     LDDT_pli     RMSD     LDDT_lp     BB_RMSD
1. L3089LG420_3 Zou_aff2 ligand_L0R_1_1.mol 0.852 1.233 0.947 0.350
2. L3089LG420_2 Zou_aff2 ligand_L0R_1_1.mol 0.738 1.795 0.906 0.582
3. L3089LG204_4 Zou ligand_L0R_1_1.mol 0.738 1.795 0.906 0.582
4. L3089LG227_5 KUMC ligand_L0R_1_1.mol 0.735 1.804 0.939 0.523
5. L3089LG420_4 Zou_aff2 ligand_L0R_1_1.mol 0.734 1.824 0.868 0.717
6. L3089LG420_1 Zou_aff2 ligand_L0R_1_1.mol 0.708 1.844 0.855 0.666
7. L3089LG204_2 Zou ligand_L0R_1_1.mol 0.708 1.844 0.855 0.666
8. L3089LG227_3 KUMC ligand_L0R_1_1.mol 0.679 1.997 0.939 0.523
9. L3089LG227_1 KUMC ligand_L0R_1_1.mol 0.663 2.148 0.939 0.523
10. L3089LG227_4 KUMC ligand_L0R_1_1.mol 0.659 2.141 0.939 0.523
11. L3089LG420_5 Zou_aff2 ligand_L0R_1_1.mol 0.622 2.835 0.918 0.427
12. L3089LG432_3 DIMAIO ligand_L0R_1_1.mol 0.580 6.749 0.930 0.322
13. L3089LG294_1 KiharaLab ligand_L0R_1_1.mol 0.570 7.586 0.926 0.583
14. L3089LG386_4 ShanghaiTech-Ligand ligand_L0R_1_1.mol 0.570 8.015 0.914 0.625
15. L3089LG298_4 ShanghaiTech-human ligand_L0R_1_1.mol 0.570 8.015 0.914 0.625
16. L3089LG432_4 DIMAIO ligand_L0R_1_1.mol 0.549 6.621 0.928 0.439
17. L3089LG432_5 DIMAIO ligand_L0R_1_1.mol 0.548 7.786 0.931 0.396
18. L3089LG298_3 ShanghaiTech-human ligand_L0R_1_1.mol 0.544 7.836 0.914 0.625
19. L3089LG386_3 ShanghaiTech-Ligand ligand_L0R_1_1.mol 0.544 7.836 0.914 0.625
20. L3089LG298_2 ShanghaiTech-human ligand_L0R_1_1.mol 0.541 7.720 0.914 0.625
21. L3089LG386_2 ShanghaiTech-Ligand ligand_L0R_1_1.mol 0.541 7.720 0.914 0.625
22. L3089LG016_4 haiping ligand_L0R_1_1.mol 0.541 8.464 0.923 0.578
23. L3089LG298_1 ShanghaiTech-human ligand_L0R_1_1.mol 0.531 7.482 0.929 0.605
24. L3089LG386_1 ShanghaiTech-Ligand ligand_L0R_1_1.mol 0.531 7.482 0.929 0.605
25. L3089LG055_2 LCDD-team ligand_L0R_1_1.mol 0.524 6.115 0.844 0.557
26. L3089LG408_2 SNU-CHEM-lig ligand_L0R_1_1.mol 0.521 8.198 0.893 0.408
27. L3089LG207_1 MULTICOM_ligand ligand_L0R_1_1.mol 0.521 8.193 0.931 0.587
28. L3089LG408_1 SNU-CHEM-lig ligand_L0R_1_1.mol 0.519 8.318 0.855 0.634
29. L3089LG274_1 kozakovvajda ligand_L0R_1_1.mol 0.516 8.126 0.923 0.350
30. L3089LG494_1 ClusPro ligand_L0R_1_1.mol 0.516 8.126 0.923 0.350
31. L3089LG274_3 kozakovvajda ligand_L0R_1_1.mol 0.516 8.126 0.923 0.350
32. L3089LG494_5 ClusPro ligand_L0R_1_1.mol 0.516 8.126 0.923 0.350
33. L3089LG274_5 kozakovvajda ligand_L0R_1_1.mol 0.516 8.126 0.923 0.350
34. L3089LG494_3 ClusPro ligand_L0R_1_1.mol 0.516 8.126 0.923 0.350
35. L3089LG016_5 haiping ligand_L0R_1_1.mol 0.505 8.309 0.923 0.578
36. L3089LG016_1 haiping ligand_L0R_1_1.mol 0.498 8.471 0.923 0.578
37. L3089LG207_2 MULTICOM_ligand ligand_L0R_1_1.mol 0.498 8.010 0.931 0.587
38. L3089LG408_3 SNU-CHEM-lig ligand_L0R_1_1.mol 0.496 8.450 0.869 0.578
39. L3089LG016_2 haiping ligand_L0R_1_1.mol 0.493 8.699 0.923 0.578
40. L3089LG408_4 SNU-CHEM-lig ligand_L0R_1_1.mol 0.489 9.040 0.806 0.836
41. L3089LG494_2 ClusPro ligand_L0R_1_1.mol 0.486 8.207 0.922 0.350
42. L3089LG494_4 ClusPro ligand_L0R_1_1.mol 0.486 8.207 0.922 0.350
43. L3089LG274_4 kozakovvajda ligand_L0R_1_1.mol 0.486 8.207 0.922 0.350
44. L3089LG274_2 kozakovvajda ligand_L0R_1_1.mol 0.486 8.207 0.922 0.350
45. L3089LG055_1 LCDD-team ligand_L0R_1_1.mol 0.485 8.456 0.844 0.557
46. L3089LG207_4 MULTICOM_ligand ligand_L0R_1_1.mol 0.482 8.694 0.846 0.672
47. L3089LG091_3 Huang-HUST ligand_L0R_1_1.mol 0.481 8.292 0.916 0.492
48. L3089LG091_5 Huang-HUST ligand_L0R_1_1.mol 0.472 8.470 0.834 0.841
49. L3089LG432_2 DIMAIO ligand_L0R_1_1.mol 0.460 4.687 0.684 1.202
50. L3089LG091_1 Huang-HUST ligand_L0R_1_1.mol 0.459 8.149 0.834 0.841
51. L3089LG091_4 Huang-HUST ligand_L0R_1_1.mol 0.455 8.351 0.834 0.841
52. L3089LG091_2 Huang-HUST ligand_L0R_1_1.mol 0.443 7.975 0.834 0.606
53. L3089LG008_4 HADDOCK ligand_L0R_1_1.mol 0.440 8.412 0.857 0.837
54. L3089LG008_3 HADDOCK ligand_L0R_1_1.mol 0.437 8.167 0.842 0.896
55. L3089LG450_3 OpenComplex_Server ligand_L0R_1_1.mol 0.435 8.105 0.851 0.818
56. L3089LG008_2 HADDOCK ligand_L0R_1_1.mol 0.434 8.148 0.830 0.932
57. L3089LG432_1 DIMAIO ligand_L0R_1_1.mol 0.433 5.614 0.845 0.569
58. L3089LG008_1 HADDOCK ligand_L0R_1_1.mol 0.430 8.231 0.847 0.944
59. L3089LG008_5 HADDOCK ligand_L0R_1_1.mol 0.416 8.362 0.810 0.928
60. L3089LG016_3 haiping ligand_L0R_1_1.mol 0.410 9.078 0.923 0.578
61. L3089LG309_4 Koes ligand_L0R_1_1.mol 0.377 8.624 0.670 1.580
62. L3089LG167_5 OpenComplex ligand_L0R_1_1.mol 0.358 10.122 0.591 2.069
63. L3089LG309_2 Koes ligand_L0R_1_1.mol 0.357 8.671 0.665 1.648
64. L3089LG262_1 CoDock ligand_L0R_1_1.mol 0.343 9.637 0.827 0.860
65. L3089LG262_5 CoDock ligand_L0R_1_1.mol 0.343 9.637 0.827 0.860
66. L3089LG262_2 CoDock ligand_L0R_1_1.mol 0.338 9.394 0.772 0.902
67. L3089LG167_4 OpenComplex ligand_L0R_1_1.mol 0.317 7.959 0.579 2.104
68. L3089LG309_3 Koes ligand_L0R_1_1.mol 0.301 8.154 0.655 1.709
69. L3089LG055_4 LCDD-team ligand_L0R_1_1.mol 0.240 9.004 0.844 0.557
70. L3089LG055_3 LCDD-team ligand_L0R_1_1.mol 0.240 9.004 0.844 0.557
71. L3089LG020_1 comppharmunibas ligand_L0R_1_1.mol 0.206 8.612 0.887 0.758
72. L3089LG309_1 Koes ligand_L0R_1_1.mol 0.195 8.291 0.665 1.648
73. L3089LG262_3 CoDock ligand_L0R_1_1.mol 0.192 9.683 0.772 0.902
74. L3089LG386_5 ShanghaiTech-Ligand ligand_L0R_1_1.mol 0.184 9.670 0.914 0.625
75. L3089LG298_5 ShanghaiTech-human ligand_L0R_1_1.mol 0.184 9.670 0.914 0.625
76. L3089LG227_2 KUMC ligand_L0R_1_1.mol 0.182 9.029 0.939 0.523
77. L3089LG082_1 VnsDock ligand_L0R_1_1.mol 0.180 9.455 0.958 0.456
78. L3089LG450_4 OpenComplex_Server ligand_L0R_1_1.mol 0.171 9.306 0.851 0.818
79. L3089LG262_4 CoDock ligand_L0R_1_1.mol 0.167 10.236 0.827 0.860
80. L3089LG204_1 Zou ligand_L0R_1_1.mol 0.166 9.135 0.892 0.665
81. L3089LG207_5 MULTICOM_ligand ligand_L0R_1_1.mol 0.164 9.035 0.931 0.587
82. L3089LG207_3 MULTICOM_ligand ligand_L0R_1_1.mol 0.164 9.035 0.931 0.587
83. L3089LG164_1 McGuffin ligand_L0R_1_1.mol 0.163 8.192 0.668 1.595
84. L3089LG167_2 OpenComplex ligand_L0R_1_1.mol 0.161 10.123 0.549 1.722
85. L3089LG167_1 OpenComplex ligand_L0R_1_1.mol 0.159 10.415 0.567 1.684
86. L3089LG164_4 McGuffin ligand_L0R_1_1.mol 0.157 9.122 0.668 1.595
87. L3089LG164_5 McGuffin ligand_L0R_1_1.mol 0.157 9.567 0.668 1.595
88. L3089LG020_2 comppharmunibas ligand_L0R_1_1.mol 0.154 11.650 0.887 0.758
89. L3089LG201_5 Drugit ligand_L0R_1_1.mol 0.153 11.187 0.858 0.510
90. L3089LG204_5 Zou ligand_L0R_1_1.mol 0.146 9.694 0.879 0.674
91. L3089LG204_3 Zou ligand_L0R_1_1.mol 0.146 9.460 0.896 0.636
92. L3089LG408_5 SNU-CHEM-lig ligand_L0R_1_1.mol 0.136 10.092 0.780 0.881
93. L3089LG055_5 LCDD-team ligand_L0R_1_1.mol 0.135 10.587 0.844 0.557
94. L3089LG201_1 Drugit ligand_L0R_1_1.mol 0.127 11.829 0.839 0.516
95. L3089LG201_3 Drugit ligand_L0R_1_1.mol 0.125 11.425 0.840 0.549
96. L3089LG450_2 OpenComplex_Server ligand_L0R_1_1.mol 0.125 11.929 0.851 0.818
97. L3089LG164_3 McGuffin ligand_L0R_1_1.mol 0.120 9.495 0.668 1.595
98. L3089LG450_1 OpenComplex_Server ligand_L0R_1_1.mol 0.119 11.826 0.851 0.818
99. L3089LG191_1 Schneidman ligand_L0R_1_1.mol 0.112 9.921 0.655 1.804
100. L3089LG191_3 Schneidman ligand_L0R_1_1.mol 0.110 10.114 0.661 1.565
101. L3089LG201_2 Drugit ligand_L0R_1_1.mol 0.100 12.533 0.839 0.536
102. L3089LG450_5 OpenComplex_Server ligand_L0R_1_1.mol 0.035 14.014 0.851 0.818
103. L3089LG464_5 PocketTracer ligand_L0R_1_1.mol 0.026 13.544 0.664 1.719
104. L3089LG464_3 PocketTracer ligand_L0R_1_1.mol 0.014 14.142 0.664 1.719
105. L3089LG464_2 PocketTracer ligand_L0R_1_1.mol 0.008 15.955 0.664 1.719
106. L3089LG464_1 PocketTracer ligand_L0R_1_1.mol 0.007 15.478 0.664 1.719
107. L3089LG464_4 PocketTracer ligand_L0R_1_1.mol 0.001 19.493 0.664 1.719
108. L3089LG201_4 Drugit ligand_L0R_1_1.mol 0.000 39.434 0.938 0.417
109. L3089LG164_2 McGuffin ligand_L0R_1_1.mol 0.000 33.234 0.677 1.600
110. L3089LG167_3 OpenComplex ligand_L0R_1_1.mol 0.000 24.093 0.531 1.845
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use